Delivery Order SPE2DB22D1106-SPE2DB25FFBS9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,872.08 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division and performed work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $1,782.75, represents a non-competitive, non-set-aside award with an ultimate completion date of July 25, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,831.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. to supply 60-count Naltrexone 50 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds...
- This is a $31,904.62 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count packages of the drug Naltrexone 50 mg tablets. The contract has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,362.28, is for the delivery of Naltrexone 50 mg tablets in 60-count packaging. It is a firm fixed-price delivery order with a performance period ending on May 6, 2025. The contract is not set aside and was awarded on May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.01 firm fixed-price delivery order is for the supply of Naltrexone 50 mg tablets to support federal medical programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,370.20 firm fixed-price delivery order is for the supply of 60-count Naltrexone 50 mg tablets. The contract has an ultimate completion date of September 11, 2024 and is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $138,740 to Amerisourcebergen Drug Corporation to provide 50mg naltrexone tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required between September 7-8, 2023. The order was placed under an existing DLA contract vehicle to support the agency's supply chain needs. No set-aside designation or subcontractors were identified. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,269.01, is for the delivery of Naltrexone 50 mg tablets to support military and government medical programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of Naltrexone 50 mg tablets, a pharmaceutical product, at a firm fixed price of $1,308.12. The contract has a completion date of December 20, 2023. Amerisourcebergen Drug Corp has received multiple federal contract awards from DLA to provide...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBS9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $47,260.15 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio primarily serving military and veteran healthcare systems through the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Naltrexone order fulfills immediate medical supply requirements within the broader pharmaceutical procurement framework established through the DLA's Indefinite Delivery Contract vehicle, which enables flexible and efficient sourcing of medications and medical commodities across multiple therapeutic domains to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.3k | 8/5/25 |